Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern
CK Heo, WH Lim, J Yang, S Son, SJ Kim… - Frontiers in …, 2023 - frontiersin.org
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative
agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global …
agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global …
[HTML][HTML] Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus
DV Shcheblyakov, DV Voronina, IA Favorskaya… - Acta …, 2024 - ncbi.nlm.nih.gov
Monoclonal antibodies and recombinant antibody fragments are a very promising
therapeutic tool to combat infectious diseases. Due to their unique paratope structure …
therapeutic tool to combat infectious diseases. Due to their unique paratope structure …